Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Dermatology and Therapy|April 6, 2022
Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USAArash Mostaghimi, Jason Xenakis, Aster Meche, et al.
Open Forum Infectious Diseases|May 14, 2023
Risk of Pneumococcal Disease in US Adults by Age and Risk ProfileLindsay R Grant, Aster Meche, Leah McGrath, et al.
Current Medical Research and Opinion|March 25, 2024
Assessment of algorithms for identifying patients with triple-class refractory multiple myeloma using real-world dataLiliya Sinyavskaya, Aster Meche, Ariane Faucher, et al.
Epidemiology (Cambridge, Mass.)|April 1, 2026
Applying the Target Study Conceptual Model to Measure Racial and Ethnic Disparities in Hypertension Treatment IntensificationAster Meche, Romsai T Boonyasai, Yea-Jen Hsu, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 19, 2026
Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST StudySatoshi Yoshihara, Aster Meche, Patrick Hlavacek, et al.
Future Oncology (London, England)|February 28, 2024
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myelomaLuciano J Costa, Thomas W LeBlanc, Hans Tesch, et al.
Blood and Lymphatic Cancer : Targets and Therapy|June 10, 2025
An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple MyelomaLuciano J Costa, Thomas W LeBlanc, Hans Tesch, et al.
Future Oncology (London, England)|April 23, 2026
Real-world treatment patterns and outcomes of patients with multiple myeloma initiating elranatamab: results from the ALTITUDE-1 and ALTITUDE-2 retrospective cohort studiesRahul Banerjee, Meera Mohan, Bhavesh Shah, et al.
Pageof 1